Found: 138
Select item for more details and to access through your institution.
Discordance between mean glucose and time in range in relation to HbA<sub>1c</sub> in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
- Published in:
- Diabetologia, 2024, v. 67, n. 8, p. 1517, doi. 10.1007/s00125-024-06151-2
- By:
- Publication type:
- Article
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013.
- Published in:
- Diabetologia, 2016, v. 59, n. 8, p. 1692, doi. 10.1007/s00125-016-3971-y
- By:
- Publication type:
- Article
Risk factors for nephropathy in persons with type 1 diabetes: a population-based study.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 6, p. 761, doi. 10.1007/s00592-022-01863-6
- By:
- Publication type:
- Article
The need for registry‐based studies in diabetes and stroke: A unique opportunity to understand whether diabetic treatments improve post‐stroke outcome.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2527, doi. 10.1111/dom.15577
- By:
- Publication type:
- Article
Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2509, doi. 10.1111/dom.15545
- By:
- Publication type:
- Article
Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase‐4 inhibitors: Real world evidence from the Nordic EMPRISE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 261, doi. 10.1111/dom.14870
- By:
- Publication type:
- Article
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5).
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 619, doi. 10.1111/dom.14257
- By:
- Publication type:
- Article
Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 182, doi. 10.1111/dom.13885
- By:
- Publication type:
- Article
Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2651, doi. 10.1111/dom.13852
- By:
- Publication type:
- Article
Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2651, doi. 10.1111/dom.13852
- By:
- Publication type:
- Article
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1136, doi. 10.1111/dom.13627
- By:
- Publication type:
- Article
Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 556, doi. 10.1111/dom.13110
- By:
- Publication type:
- Article
Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 344, doi. 10.1111/dom.13077
- By:
- Publication type:
- Article
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 831, doi. 10.1111/dom.12889
- By:
- Publication type:
- Article
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81).
- Published in:
- Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 882, doi. 10.4093/dmj.2023.0355
- By:
- Publication type:
- Article
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
- Published in:
- Diabetes & Metabolism Journal, 2023, v. 47, n. 5, p. 668, doi. 10.4093/dmj.2022.0342
- By:
- Publication type:
- Article
Artificial Hsp104-mediated systems for re-localizing protein aggregates.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37706-3
- By:
- Publication type:
- Article
Managing Circular Business Model Uncertainties with Future Adaptive Design.
- Published in:
- Sustainability (2071-1050), 2021, v. 13, n. 18, p. 10361, doi. 10.3390/su131810361
- By:
- Publication type:
- Article
A stochastic automaton shows how enzyme assemblies may contribute to metabolic efficiency.
- Published in:
- BMC Systems Biology, 2008, v. 2, p. 1, doi. 10.1186/1752-0509-2-27
- By:
- Publication type:
- Article
The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02174-6
- By:
- Publication type:
- Article
Effects of exenatide on coronary stent's endothelialization in subjects with type 2 diabetes: a randomized controlled trial. The Rebuild study.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-02071-4
- By:
- Publication type:
- Article
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01963-9
- By:
- Publication type:
- Article
Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01791-x
- By:
- Publication type:
- Article
Correction: Admission glucose as a prognostic marker for all-cause mortality and cardiovascular disease.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Admission glucose as a prognostic marker for all-cause mortality and cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01699-y
- By:
- Publication type:
- Article
Admission glucose as a prognostic marker for all-cause mortality and cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01699-y
- By:
- Publication type:
- Article
Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01719-x
- By:
- Publication type:
- Article
Syntaxin 5‐dependent phosphorylation of the small heat shock protein Hsp42 and its role in protein quality control.
- Published in:
- FEBS Journal, 2023, v. 290, n. 19, p. 4744, doi. 10.1111/febs.16886
- By:
- Publication type:
- Article
Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.
- Published in:
- Pituitary, 2011, v. 14, n. 3, p. 199, doi. 10.1007/s11102-010-0277-9
- By:
- Publication type:
- Article
Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting.
- Published in:
- Heart & Vessels, 2017, v. 32, n. 3, p. 269, doi. 10.1007/s00380-016-0875-1
- By:
- Publication type:
- Article
Antidiabetic Agents and Endothelial Dysfunction - Beyond Glucose Control.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2015, v. 117, n. 1, p. 15, doi. 10.1111/bcpt.12402
- By:
- Publication type:
- Article
Three‐dimensional product circularity.
- Published in:
- Journal of Industrial Ecology, 2021, v. 25, n. 4, p. 824, doi. 10.1111/jiec.13109
- By:
- Publication type:
- Article
Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study.
- Published in:
- Frontiers in Endocrinology, 2017, p. 1, doi. 10.3389/fendo.2017.00325
- By:
- Publication type:
- Article
Studying Spatial Protein Quality Control, Proteopathies, and Aging Using Different Model Misfolding Proteins in S. cerevisiae.
- Published in:
- Frontiers in Molecular Neuroscience, 2018, p. N.PAG, doi. 10.3389/fnmol.2018.00249
- By:
- Publication type:
- Article
How and why do toxic conformers of aberrant proteins accumulate during ageing?
- Published in:
- Essays in Biochemistry, 2017, v. 61, n. 3, p. 317, doi. 10.1042/EBC20160085
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Activation Does Not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.
- Published in:
- Journal of Vascular Research, 2015, v. 52, n. 1, p. 41, doi. 10.1159/000381097
- By:
- Publication type:
- Article
DPP-4 Inhibitor and Sulfonylurea Differentially Reverse Type 2 Diabetes-Induced Blood-Brain Barrier Leakage and Normalise Capillary Pericyte Coverage.
- Published in:
- 2023
- By:
- Publication type:
- journal article
127-LB: Effectiveness and Safety of Empagliflozin in Routine Care in Europe and East Asia: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-127-LB
- By:
- Publication type:
- Article
Regulation of Glycemia in the Recovery Phase After Stroke Counteracts the Detrimental Effect of Obesity-Induced Type 2 Diabetes on Neurological Recovery.
- Published in:
- 2020
- By:
- Publication type:
- journal article
232-LB: Cardiovascular Complications in T1D and T2D Patients Show More Similarities than Differences.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-232-LB
- By:
- Publication type:
- Article
The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain.
- Published in:
- Diabetes, 2013, v. 62, n. 4, p. 1289, doi. 10.2337/db12-0988
- By:
- Publication type:
- Article
The Pre-Stroke Induction and Normalization of Insulin Resistance Respectively Worsens and Improves Functional Recovery.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3989, doi. 10.3390/ijms24043989
- By:
- Publication type:
- Article
Admission glucose as a prognostic marker for all-cause mortality and cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01699-y
- By:
- Publication type:
- Article
Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01426-z
- By:
- Publication type:
- Article
Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01394-4
- By:
- Publication type:
- Article
Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort study.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01282-x
- By:
- Publication type:
- Article
Metabolic control of the Escherichia coli universal stress protein response through fructose-6-phosphate.
- Published in:
- Molecular Microbiology, 2007, v. 65, n. 4, p. 968, doi. 10.1111/j.1365-2958.2007.05838.x
- By:
- Publication type:
- Article
Nonculturable bacteria: programmed survival forms or cells at death's door?
- Published in:
- BioEssays, 2003, v. 25, n. 3, p. 204
- By:
- Publication type:
- Article